Lower Baseline BMI Predicts Weight Loss At 6 Months With Liraglutide

Lower baseline body mass index (BMI) and early weight loss at 3 months with liraglutide (Victoza, Saxenda) were correlated to significant weight reductions, according to results of a study published in BMC Endocrine Disorders. The study authors…

Continue Reading